All AboardInovio’s SynCon® WT1 Cancer Antigen Breaks Tolerance, Highlights Potential for Universal Cancer Immunotherapy
Read more at https://www.stockhouse.com/news/press-releases/2017/02/27/inovios-syncon-wt1-cancer-antigen-breaks-tolerance-highlights-potential-for-uni#awjuGP43OGvrpST2.99